BIIB
HealthcareBiogen Inc.
$183.58-1.32 (-0.71%)
Prev Close
$184.90
Open
$185.99
High
$188.00
Low
$183.10
Volume
484.1K
Market Cap
$27.14B
P/E
20.89
Div Yield
—
Over the past 12 months, insider activity at Biogen Inc. (BIIB) has been dominated by selling, with 3 insider purchases totaling $152.7K and 19 insider sales totaling $9.02M. The most recent insider transaction was by Murphy Nicole (officer: Head of Pharm Ops and Tech), who purchased $585.11 worth of shares on Feb 17, 2026. Biogen Inc. operates in the Healthcare sector, within the Drug Manufacturers - General industry, with a market cap of $27.14B.
Buys (12M)
3
$152.7K
Sells (12M)
19
$9.02M
Net Activity
Net Seller
$8.87M
Active Insiders
12
last 12 mo
BIIB Price Chart
BIIB Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Feb 17, 2026↗ | Murphy Nicole | officer: Head of Pharm Ops and Tech | Buy | 3 | $195.04 | $585.11 | 19,611 |
| Feb 12, 2026↗ | Murphy Nicole | Head of Pharm Ops and Tech | Buy | 3 | $195.04 | $585.11 | 0 |
| Feb 10, 2026↗ | Singhal Priya | officer: Head of Development | Sell | 2,660 | $199.83 | $531.5K | 8,043.14 |
| Feb 6, 2026↗ | ALEXANDER SUSAN H | EVP Chief Legal Officer | Sell | 3,504 | $201.18 | $704.9K | 0 |
| Feb 6, 2026↗ | Godbout Sean | Chief Accounting Officer | Sell | 359 | $201.18 | $72.2K | 0 |
| Feb 6, 2026↗ | Gregory Ginger | EVP, Human Resources | Sell | 2,589 | $201.18 | $520.9K | 0 |
| Feb 6, 2026↗ | Grogan Jane | Head of Research | Sell | 991 | $201.18 | $199.4K | 0 |
| Feb 6, 2026↗ | Izzar Rachid | Head of Global Product Strat. | Sell | 2,038 | $201.18 | $410.0K | 0 |
| Feb 6, 2026↗ | Keeney Adam | Head of Corporate Development | Sell | 1,583 | $201.18 | $318.5K | 0 |
| Feb 6, 2026↗ | Kramer Robin | Chief Financial Officer | Sell | 1,543 | $201.18 | $310.4K | 0 |
| Feb 6, 2026↗ | Murphy Nicole | Head of Pharm Ops and Tech | Sell | 3,339 | $201.18 | $671.7K | 0 |
| Feb 6, 2026↗ | Singhal Priya | Head of Development | Sell | 5,128 | $200.48 | $1.03M | 0 |
| Feb 6, 2026↗ | Viehbacher Christopher | President and CEO | Sell | 10,980 | $201.18 | $2.21M | 0 |
| Feb 3, 2026↗ | Singhal Priya | officer: Head of Development | Sell | 2,078 | $179.47 | $372.9K | 6,271.14 |
| Dec 3, 2025↗ | Viehbacher Christopher | President and CEO | Sell | 3,404 | $177.78 | $605.2K | 0 |
| Nov 4, 2025↗ | Grogan Jane | Head of Research | Sell | 337 | $154.27 | $52.0K | 0 |
| Oct 6, 2025↗ | Godbout Sean | Chief Accounting Officer | Sell | 8 | $155.25 | $1.2K | 0 |
| Sep 2, 2025↗ | Singhal Priya | Head of Development | Sell | 1,324 | $132.74 | $175.7K | 0 |
| Jul 16, 2025↗ | Izzar Rachid | Head of Global Product Strat. | Sell | 2,223 | $135.00 | $300.1K | 0 |
| May 20, 2025↗ | Singhal Priya | Head of Development | Sell | 3,806 | $126.25 | $480.5K | 0 |
| May 5, 2025↗ | DORSA CAROLINE | Director | Buy | 1,235 | $122.72 | $151.6K | 0 |
| May 5, 2025↗ | Keeney Adam | Head of Corporate Development | Sell | 454 | $120.93 | $54.9K | 0 |
| Mar 10, 2025↗ | SHERWIN STEPHEN A | Director | Sell | 8,760 | $150.02 | $1.31M | 0 |
| Feb 12, 2025↗ | ALEXANDER SUSAN H | EVP Chief Legal Officer | Sell | 807 | $142.54 | $115.0K | 0 |
| Feb 12, 2025↗ | Gregory Ginger | EVP, Human Resources | Sell | 634 | $142.54 | $90.4K | 0 |
| Feb 12, 2025↗ | Izzar Rachid | Head of Global Product Strat. | Sell | 445 | $142.54 | $63.4K | 0 |
| Feb 12, 2025↗ | Kramer Robin | Chief Accounting Officer | Sell | 245 | $142.54 | $34.9K | 0 |
| Feb 12, 2025↗ | MCDONNELL MICHAEL R | EVP, Chief Financial Officer | Sell | 1,371 | $142.54 | $195.4K | 0 |
| Feb 12, 2025↗ | Murphy Nicole | Head of Pharm Ops and Tech | Sell | 670 | $142.54 | $95.5K | 0 |
| Feb 12, 2025↗ | Singhal Priya | Head of Development | Sell | 357 | $142.54 | $50.9K | 0 |
| Feb 11, 2025↗ | Izzar Rachid | Head of Global Product Strat. | Sell | 1,165 | $141.35 | $164.7K | 0 |
| Feb 10, 2025↗ | ALEXANDER SUSAN H | EVP Chief Legal Officer | Sell | 1,234 | $141.35 | $174.4K | 0 |
| Feb 10, 2025↗ | Gregory Ginger | EVP, Human Resources | Sell | 1,040 | $141.35 | $147.0K | 0 |
| Feb 10, 2025↗ | Grogan Jane | Head of Research | Sell | 443 | $141.35 | $62.6K | 0 |
| Feb 10, 2025↗ | Keeney Adam | Head of Corporate Development | Sell | 563 | $141.35 | $79.6K | 0 |
| Feb 10, 2025↗ | Kramer Robin | Chief Accounting Officer | Sell | 476 | $141.35 | $67.3K | 0 |
| Feb 10, 2025↗ | MCDONNELL MICHAEL R | EVP, Chief Financial Officer | Sell | 1,502 | $141.35 | $212.3K | 0 |
| Feb 10, 2025↗ | Murphy Nicole | Head of Pharm Ops and Tech | Sell | 1,223 | $141.35 | $172.9K | 0 |
| Feb 10, 2025↗ | Singhal Priya | Head of Development | Sell | 681 | $141.35 | $96.3K | 0 |
| Feb 10, 2025↗ | Viehbacher Christopher | President and CEO | Sell | 3,201 | $141.35 | $452.5K | 0 |
| Jan 31, 2025↗ | Singhal Priya | Head of Development | Sell | 578 | $143.93 | $83.2K | 0 |
| Dec 6, 2024↗ | Kramer Robin | Chief Accounting Officer | Sell | 170 | $157.78 | $26.8K | 0 |
| Dec 6, 2024↗ | Singhal Priya | Head of Development | Sell | 316 | $157.58 | $49.8K | 0 |
| Nov 1, 2024↗ | Grogan Jane | Head of Research | Sell | 204 | $173.79 | $35.5K | 0 |
| Aug 30, 2024↗ | Singhal Priya | Head of Development | Sell | 1,238 | $204.57 | $253.3K | 0 |
| May 1, 2024↗ | Keeney Adam | Head of Corporate Development | Sell | 276 | $216.13 | $59.7K | 0 |
| Apr 2, 2024↗ | Singhal Priya | Head of Development | Sell | 93 | $213.09 | $19.8K | 0 |
| Apr 1, 2024↗ | Murphy Nicole | Head of Pharm Ops and Tech | Sell | 117 | $214.83 | $25.1K | 0 |
| Feb 22, 2024↗ | Singhal Priya | Head of Development | Sell | 262 | $221.23 | $58.0K | 0 |
| Feb 16, 2024↗ | ALEXANDER SUSAN H | EVP Chief Legal Officer | Sell | 2,437 | $219.08 | $533.9K | 0 |
| Feb 16, 2024↗ | Gregory Ginger | EVP, Human Resources | Sell | 2,264 | $219.08 | $496.0K | 0 |
| Feb 16, 2024↗ | Izzar Rachid | Head of Global Product Strat. | Sell | 952 | $219.08 | $208.6K | 0 |
| Feb 16, 2024↗ | Kramer Robin | Chief Accounting Officer | Sell | 396 | $219.08 | $86.8K | 0 |
| Feb 16, 2024↗ | MCDONNELL MICHAEL R | EVP, Chief Financial Officer | Sell | 3,438 | $219.08 | $753.2K | 0 |
| Feb 16, 2024↗ | Murphy Nicole | Head of Pharm Ops and Tech | Sell | 610 | $219.08 | $133.6K | 0 |
| Feb 16, 2024↗ | Singhal Priya | Head of Development | Sell | 576 | $219.53 | $126.5K | 0 |
| Feb 15, 2024↗ | Rowinsky Eric K | Director | Buy | 455 | $222.54 | $101.3K | 0 |
| Feb 9, 2024↗ | ALEXANDER SUSAN H | EVP Chief Legal Officer | Sell | 938 | $240.98 | $226.0K | 0 |
| Feb 9, 2024↗ | Gregory Ginger | EVP, Human Resources | Sell | 634 | $240.98 | $152.8K | 0 |
| Feb 9, 2024↗ | Izzar Rachid | Head of Global Product Strat. | Sell | 445 | $240.98 | $107.2K | 0 |
| Feb 9, 2024↗ | Kramer Robin | Chief Accounting Officer | Sell | 245 | $240.98 | $59.0K | 0 |
| Feb 9, 2024↗ | MCDONNELL MICHAEL R | EVP, Chief Financial Officer | Sell | 1,431 | $240.98 | $344.8K | 0 |
| Feb 9, 2024↗ | Murphy Nicole | Head of Pharm Ops and Tech | Sell | 761 | $240.98 | $183.4K | 0 |
| Feb 9, 2024↗ | Singhal Priya | Head of Development | Sell | 793 | $240.17 | $190.5K | 0 |
| Feb 7, 2024↗ | ALEXANDER SUSAN H | EVP Chief Legal Officer | Sell | 655 | $240.30 | $157.4K | 0 |
| Feb 7, 2024↗ | Gregory Ginger | EVP, Human Resources | Sell | 498 | $240.30 | $119.7K | 0 |
| Feb 7, 2024↗ | Izzar Rachid | Head of Global Product Strat. | Sell | 621 | $240.30 | $149.2K | 0 |
| Feb 7, 2024↗ | Kramer Robin | Chief Accounting Officer | Sell | 253 | $240.30 | $60.8K | 0 |
| Feb 7, 2024↗ | MCDONNELL MICHAEL R | EVP, Chief Financial Officer | Sell | 765 | $240.30 | $183.8K | 0 |
| Feb 7, 2024↗ | Murphy Nicole | Head of Pharm Ops and Tech | Sell | 638 | $240.30 | $153.3K | 0 |
| Feb 1, 2024↗ | Singhal Priya | Head of Development | Sell | 1,195 | $246.82 | $295.0K | 0 |
| Dec 8, 2023↗ | Kramer Robin | Chief Accounting Officer | Sell | 170 | $239.29 | $40.7K | 0 |
| Dec 8, 2023↗ | Singhal Priya | Head of Development | Sell | 316 | $242.32 | $76.6K | 0 |
| Sep 1, 2023↗ | MCDONNELL MICHAEL R | EVP, Chief Financial Officer | Sell | 2,704 | $267.17 | $722.4K | 0 |
| Sep 1, 2023↗ | Singhal Priya | Head of Development | Sell | 1,238 | $267.96 | $331.7K | 0 |
| Jun 30, 2023↗ | Izzar Rachid | Head of Global Product Strat. | Sell | 244 | $284.85 | $69.5K | 0 |
| Jun 30, 2023↗ | Kramer Robin | Chief Accounting Officer | Sell | 122 | $284.85 | $34.8K | 0 |
| Jun 30, 2023↗ | Singhal Priya | Head of Development | Sell | 234 | $284.16 | $66.5K | 0 |
| Apr 28, 2023↗ | Gregory Ginger | EVP, Human Resources | Sell | 2,681 | $300.00 | $804.3K | 0 |
| Apr 4, 2023↗ | Singhal Priya | Head of Development | Sell | 91 | $277.11 | $25.2K | 0 |
| Mar 31, 2023↗ | Murphy Nicole | Head of Pharm Ops and Tech | Sell | 116 | $278.03 | $32.3K | 0 |
| Mar 28, 2023↗ | Singhal Priya | Head of Development | Sell | 568 | $270.06 | $153.4K | 0 |
| Mar 2, 2023↗ | Singhal Priya | Head of Development | Sell | 687 | $268.75 | $184.6K | 0 |
| Feb 17, 2023↗ | ALEXANDER SUSAN H | EVP Chief Legal Off & Corp Sec | Sell | 929 | $278.38 | $258.6K | 0 |
| Feb 17, 2023↗ | Gregory Ginger | EVP, Human Resources | Sell | 867 | $278.38 | $241.4K | 0 |
| Feb 17, 2023↗ | Izzar Rachid | Head of Global Product Strat. | Sell | 371 | $278.38 | $103.3K | 0 |
| Feb 17, 2023↗ | Kramer Robin | Chief Accounting Officer | Sell | 238 | $278.38 | $66.3K | 0 |
| Feb 17, 2023↗ | MCDONNELL MICHAEL R | EVP, Chief Financial Officer | Sell | 1,310 | $278.38 | $364.7K | 0 |
| Feb 17, 2023↗ | Murphy Nicole | Head of Pharm Ops and Tech | Sell | 233 | $278.38 | $64.9K | 0 |
| Feb 17, 2023↗ | Singhal Priya | Head of Development | Sell | 151 | $278.38 | $42.0K | 0 |
| Feb 10, 2023↗ | ALEXANDER SUSAN H | EVP Chief Legal Off & Corp Sec | Sell | 4,202 | $286.30 | $1.20M | 0 |
| Feb 10, 2023↗ | Gregory Ginger | EVP, Human Resources | Sell | 3,306 | $286.30 | $946.5K | 0 |
| Feb 10, 2023↗ | Izzar Rachid | Head of Global Product Strat. | Sell | 1,324 | $286.30 | $379.1K | 0 |
| Feb 10, 2023↗ | Kramer Robin | Chief Accounting Officer | Sell | 590 | $286.30 | $168.9K | 0 |
| Feb 10, 2023↗ | MCDONNELL MICHAEL R | EVP, Chief Financial Officer | Sell | 1,105 | $286.30 | $316.4K | 0 |
| Feb 10, 2023↗ | Murphy Nicole | Head of Pharm Ops and Tech | Sell | 1,387 | $286.30 | $397.1K | 0 |
| Feb 10, 2023↗ | Singhal Priya | Head of Development | Sell | 372 | $286.30 | $106.5K | 0 |
| Dec 8, 2022↗ | Kramer Robin | Chief Accounting Officer | Sell | 156 | $289.10 | $45.1K | 0 |
| Dec 2, 2022↗ | Izzar Rachid | Head of Alzheimer's Disease | Sell | 759 | $298.90 | $226.9K | 0 |
| Dec 2, 2022↗ | Murphy Nicole | Head of Pharm Ops and Tech | Sell | 39 | $298.90 | $11.7K | 0 |
| Nov 14, 2022↗ | Gregory Ginger | EVP, Human Resources | Sell | 5,610 | $300.11 | $1.68M | 0 |
| Oct 27, 2022↗ | ALEXANDER SUSAN H | EVP Chief Legal Off & Corp Sec | Sell | 5,532 | $280.70 | $1.55M | 0 |
| Sep 1, 2022↗ | MCDONNELL MICHAEL R | EVP, Chief Financial Officer | Sell | 2,428 | $199.79 | $485.1K | 0 |
| Aug 1, 2022↗ | Murphy Nicole | Head of Pharm Ops and Tech | Sell | 319 | $209.26 | $66.8K | 0 |
| Jul 1, 2022↗ | Izzar Rachid | Head of Alzheimer's Disease | Sell | 148 | $210.63 | $31.2K | 0 |
| Jul 1, 2022↗ | Kramer Robin | Chief Accounting Officer | Sell | 74 | $210.63 | $15.6K | 0 |
| Apr 1, 2022↗ | Murphy Nicole | Head of Pharm Ops and Tech | Sell | 84 | $210.65 | $17.7K | 0 |
| Feb 18, 2022↗ | ALEXANDER SUSAN H | EVP Chief Legal Off & Corp Sec | Sell | 659 | $209.79 | $138.3K | 0 |
| Feb 18, 2022↗ | Gregory Ginger | EVP, Human Resources | Sell | 616 | $209.79 | $129.2K | 0 |
| Feb 18, 2022↗ | Guindo Chirfi | Head of Glob Prod Strat & Com | Sell | 879 | $209.79 | $184.4K | 0 |
| Feb 18, 2022↗ | Izzar Rachid | Head of Alzheimer's Disease | Sell | 175 | $209.79 | $36.7K | 0 |
| Feb 18, 2022↗ | Kramer Robin | Chief Accounting Officer | Sell | 117 | $209.79 | $24.5K | 0 |
| Feb 18, 2022↗ | MCDONNELL MICHAEL R | EVP, Chief Financial Officer | Sell | 977 | $209.79 | $205.0K | 0 |
| Feb 18, 2022↗ | Murphy Nicole | Head of Pharm Ops and Tech | Sell | 110 | $209.79 | $23.1K | 0 |
| Feb 18, 2022↗ | Vounatsos Michel | Chief Executive Officer | Sell | 2,746 | $209.79 | $576.1K | 0 |
| Feb 12, 2022↗ | ALEXANDER SUSAN H | EVP Chief Legal Off & Corp Sec | Sell | 2,056 | $214.59 | $441.2K | 0 |
| Feb 12, 2022↗ | Gregory Ginger | EVP, Human Resources | Sell | 1,252 | $214.59 | $268.7K | 0 |
| Feb 12, 2022↗ | Guindo Chirfi | Head of Glob Prod Strat & Com | Sell | 2,342 | $214.59 | $502.6K | 0 |
| Feb 12, 2022↗ | Izzar Rachid | Head of Alzheimer's Disease | Sell | 122 | $214.59 | $26.2K | 0 |
| Feb 12, 2022↗ | Kramer Robin | Chief Accounting Officer | Sell | 171 | $214.59 | $36.7K | 0 |
| Feb 12, 2022↗ | Murphy Nicole | Head of Pharm Ops and Tech | Sell | 92 | $214.59 | $19.7K | 0 |
| Feb 12, 2022↗ | Vounatsos Michel | Chief Executive Officer | Sell | 8,566 | $214.59 | $1.84M | 0 |
| Dec 3, 2021↗ | Kramer Robin | Chief Accounting Officer | Sell | 100 | $223.92 | $22.4K | 0 |
| Dec 2, 2021↗ | Izzar Rachid | Head of Alzheimer's Disease | Sell | 165 | $228.52 | $37.7K | 0 |
| Sep 1, 2021↗ | MCDONNELL MICHAEL R | EVP, Chief Financial Officer | Sell | 2,582 | $338.24 | $873.3K | 0 |
| Jul 1, 2021↗ | Kramer Robin | Chief Accounting Officer | Sell | 74 | $348.92 | $25.8K | 0 |
| Jun 7, 2021↗ | Guindo Chirfi | Head of Glob Prod Strat & Com | Sell | 3,087 | $440.00 | $1.36M | 0 |
| Jun 7, 2021↗ | Sandrock Alfred | Head of Research & Development | Sell | 7,672 | $440.00 | $3.38M | 0 |
| Jun 4, 2021↗ | Posner Brian S | Director | Sell | 360 | $274.17 | $98.7K | 0 |
BIIB Insider Buying Activity
The following table shows recent insider purchases of Biogen Inc. (BIIB) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Feb 17, 2026↗ | Murphy Nicole | officer: Head of Pharm Ops and Tech | Buy | 3 | $195.04 | $585.11 | 19,611 |
| Feb 12, 2026↗ | Murphy Nicole | Head of Pharm Ops and Tech | Buy | 3 | $195.04 | $585.11 | 0 |
| May 5, 2025↗ | DORSA CAROLINE | Director | Buy | 1,235 | $122.72 | $151.6K | 0 |
| Feb 15, 2024↗ | Rowinsky Eric K | Director | Buy | 455 | $222.54 | $101.3K | 0 |
BIIB Insider Selling Activity
The following table shows recent insider sales of Biogen Inc. (BIIB) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Feb 10, 2026↗ | Singhal Priya | officer: Head of Development | Sell | 2,660 | $199.83 | $531.5K | 8,043.14 |
| Feb 6, 2026↗ | ALEXANDER SUSAN H | EVP Chief Legal Officer | Sell | 3,504 | $201.18 | $704.9K | 0 |
| Feb 6, 2026↗ | Godbout Sean | Chief Accounting Officer | Sell | 359 | $201.18 | $72.2K | 0 |
| Feb 6, 2026↗ | Gregory Ginger | EVP, Human Resources | Sell | 2,589 | $201.18 | $520.9K | 0 |
| Feb 6, 2026↗ | Grogan Jane | Head of Research | Sell | 991 | $201.18 | $199.4K | 0 |
| Feb 6, 2026↗ | Izzar Rachid | Head of Global Product Strat. | Sell | 2,038 | $201.18 | $410.0K | 0 |
| Feb 6, 2026↗ | Keeney Adam | Head of Corporate Development | Sell | 1,583 | $201.18 | $318.5K | 0 |
| Feb 6, 2026↗ | Kramer Robin | Chief Financial Officer | Sell | 1,543 | $201.18 | $310.4K | 0 |
| Feb 6, 2026↗ | Murphy Nicole | Head of Pharm Ops and Tech | Sell | 3,339 | $201.18 | $671.7K | 0 |
| Feb 6, 2026↗ | Singhal Priya | Head of Development | Sell | 5,128 | $200.48 | $1.03M | 0 |
| Feb 6, 2026↗ | Viehbacher Christopher | President and CEO | Sell | 10,980 | $201.18 | $2.21M | 0 |
| Feb 3, 2026↗ | Singhal Priya | officer: Head of Development | Sell | 2,078 | $179.47 | $372.9K | 6,271.14 |
| Dec 3, 2025↗ | Viehbacher Christopher | President and CEO | Sell | 3,404 | $177.78 | $605.2K | 0 |
| Nov 4, 2025↗ | Grogan Jane | Head of Research | Sell | 337 | $154.27 | $52.0K | 0 |
| Oct 6, 2025↗ | Godbout Sean | Chief Accounting Officer | Sell | 8 | $155.25 | $1.2K | 0 |
| Sep 2, 2025↗ | Singhal Priya | Head of Development | Sell | 1,324 | $132.74 | $175.7K | 0 |
| Jul 16, 2025↗ | Izzar Rachid | Head of Global Product Strat. | Sell | 2,223 | $135.00 | $300.1K | 0 |
| May 20, 2025↗ | Singhal Priya | Head of Development | Sell | 3,806 | $126.25 | $480.5K | 0 |
| May 5, 2025↗ | Keeney Adam | Head of Corporate Development | Sell | 454 | $120.93 | $54.9K | 0 |
| Mar 10, 2025↗ | SHERWIN STEPHEN A | Director | Sell | 8,760 | $150.02 | $1.31M | 0 |
| Feb 12, 2025↗ | ALEXANDER SUSAN H | EVP Chief Legal Officer | Sell | 807 | $142.54 | $115.0K | 0 |
| Feb 12, 2025↗ | Gregory Ginger | EVP, Human Resources | Sell | 634 | $142.54 | $90.4K | 0 |
| Feb 12, 2025↗ | Izzar Rachid | Head of Global Product Strat. | Sell | 445 | $142.54 | $63.4K | 0 |
| Feb 12, 2025↗ | Kramer Robin | Chief Accounting Officer | Sell | 245 | $142.54 | $34.9K | 0 |
| Feb 12, 2025↗ | MCDONNELL MICHAEL R | EVP, Chief Financial Officer | Sell | 1,371 | $142.54 | $195.4K | 0 |
| Feb 12, 2025↗ | Murphy Nicole | Head of Pharm Ops and Tech | Sell | 670 | $142.54 | $95.5K | 0 |
| Feb 12, 2025↗ | Singhal Priya | Head of Development | Sell | 357 | $142.54 | $50.9K | 0 |
| Feb 11, 2025↗ | Izzar Rachid | Head of Global Product Strat. | Sell | 1,165 | $141.35 | $164.7K | 0 |
| Feb 10, 2025↗ | ALEXANDER SUSAN H | EVP Chief Legal Officer | Sell | 1,234 | $141.35 | $174.4K | 0 |
| Feb 10, 2025↗ | Gregory Ginger | EVP, Human Resources | Sell | 1,040 | $141.35 | $147.0K | 0 |
| Feb 10, 2025↗ | Grogan Jane | Head of Research | Sell | 443 | $141.35 | $62.6K | 0 |
| Feb 10, 2025↗ | Keeney Adam | Head of Corporate Development | Sell | 563 | $141.35 | $79.6K | 0 |
| Feb 10, 2025↗ | Kramer Robin | Chief Accounting Officer | Sell | 476 | $141.35 | $67.3K | 0 |
| Feb 10, 2025↗ | MCDONNELL MICHAEL R | EVP, Chief Financial Officer | Sell | 1,502 | $141.35 | $212.3K | 0 |
| Feb 10, 2025↗ | Murphy Nicole | Head of Pharm Ops and Tech | Sell | 1,223 | $141.35 | $172.9K | 0 |
| Feb 10, 2025↗ | Singhal Priya | Head of Development | Sell | 681 | $141.35 | $96.3K | 0 |
| Feb 10, 2025↗ | Viehbacher Christopher | President and CEO | Sell | 3,201 | $141.35 | $452.5K | 0 |
| Jan 31, 2025↗ | Singhal Priya | Head of Development | Sell | 578 | $143.93 | $83.2K | 0 |
| Dec 6, 2024↗ | Kramer Robin | Chief Accounting Officer | Sell | 170 | $157.78 | $26.8K | 0 |
| Dec 6, 2024↗ | Singhal Priya | Head of Development | Sell | 316 | $157.58 | $49.8K | 0 |
| Nov 1, 2024↗ | Grogan Jane | Head of Research | Sell | 204 | $173.79 | $35.5K | 0 |
| Aug 30, 2024↗ | Singhal Priya | Head of Development | Sell | 1,238 | $204.57 | $253.3K | 0 |
| May 1, 2024↗ | Keeney Adam | Head of Corporate Development | Sell | 276 | $216.13 | $59.7K | 0 |
| Apr 2, 2024↗ | Singhal Priya | Head of Development | Sell | 93 | $213.09 | $19.8K | 0 |
| Apr 1, 2024↗ | Murphy Nicole | Head of Pharm Ops and Tech | Sell | 117 | $214.83 | $25.1K | 0 |
| Feb 22, 2024↗ | Singhal Priya | Head of Development | Sell | 262 | $221.23 | $58.0K | 0 |
| Feb 16, 2024↗ | ALEXANDER SUSAN H | EVP Chief Legal Officer | Sell | 2,437 | $219.08 | $533.9K | 0 |
| Feb 16, 2024↗ | Gregory Ginger | EVP, Human Resources | Sell | 2,264 | $219.08 | $496.0K | 0 |
| Feb 16, 2024↗ | Izzar Rachid | Head of Global Product Strat. | Sell | 952 | $219.08 | $208.6K | 0 |
| Feb 16, 2024↗ | Kramer Robin | Chief Accounting Officer | Sell | 396 | $219.08 | $86.8K | 0 |
| Feb 16, 2024↗ | MCDONNELL MICHAEL R | EVP, Chief Financial Officer | Sell | 3,438 | $219.08 | $753.2K | 0 |
| Feb 16, 2024↗ | Murphy Nicole | Head of Pharm Ops and Tech | Sell | 610 | $219.08 | $133.6K | 0 |
| Feb 16, 2024↗ | Singhal Priya | Head of Development | Sell | 576 | $219.53 | $126.5K | 0 |
| Feb 9, 2024↗ | ALEXANDER SUSAN H | EVP Chief Legal Officer | Sell | 938 | $240.98 | $226.0K | 0 |
| Feb 9, 2024↗ | Gregory Ginger | EVP, Human Resources | Sell | 634 | $240.98 | $152.8K | 0 |
| Feb 9, 2024↗ | Izzar Rachid | Head of Global Product Strat. | Sell | 445 | $240.98 | $107.2K | 0 |
| Feb 9, 2024↗ | Kramer Robin | Chief Accounting Officer | Sell | 245 | $240.98 | $59.0K | 0 |
| Feb 9, 2024↗ | MCDONNELL MICHAEL R | EVP, Chief Financial Officer | Sell | 1,431 | $240.98 | $344.8K | 0 |
| Feb 9, 2024↗ | Murphy Nicole | Head of Pharm Ops and Tech | Sell | 761 | $240.98 | $183.4K | 0 |
| Feb 9, 2024↗ | Singhal Priya | Head of Development | Sell | 793 | $240.17 | $190.5K | 0 |
| Feb 7, 2024↗ | ALEXANDER SUSAN H | EVP Chief Legal Officer | Sell | 655 | $240.30 | $157.4K | 0 |
| Feb 7, 2024↗ | Gregory Ginger | EVP, Human Resources | Sell | 498 | $240.30 | $119.7K | 0 |
| Feb 7, 2024↗ | Izzar Rachid | Head of Global Product Strat. | Sell | 621 | $240.30 | $149.2K | 0 |
| Feb 7, 2024↗ | Kramer Robin | Chief Accounting Officer | Sell | 253 | $240.30 | $60.8K | 0 |
| Feb 7, 2024↗ | MCDONNELL MICHAEL R | EVP, Chief Financial Officer | Sell | 765 | $240.30 | $183.8K | 0 |
| Feb 7, 2024↗ | Murphy Nicole | Head of Pharm Ops and Tech | Sell | 638 | $240.30 | $153.3K | 0 |
| Feb 1, 2024↗ | Singhal Priya | Head of Development | Sell | 1,195 | $246.82 | $295.0K | 0 |
| Dec 8, 2023↗ | Kramer Robin | Chief Accounting Officer | Sell | 170 | $239.29 | $40.7K | 0 |
| Dec 8, 2023↗ | Singhal Priya | Head of Development | Sell | 316 | $242.32 | $76.6K | 0 |
| Sep 1, 2023↗ | MCDONNELL MICHAEL R | EVP, Chief Financial Officer | Sell | 2,704 | $267.17 | $722.4K | 0 |
| Sep 1, 2023↗ | Singhal Priya | Head of Development | Sell | 1,238 | $267.96 | $331.7K | 0 |
| Jun 30, 2023↗ | Izzar Rachid | Head of Global Product Strat. | Sell | 244 | $284.85 | $69.5K | 0 |
| Jun 30, 2023↗ | Kramer Robin | Chief Accounting Officer | Sell | 122 | $284.85 | $34.8K | 0 |
| Jun 30, 2023↗ | Singhal Priya | Head of Development | Sell | 234 | $284.16 | $66.5K | 0 |
| Apr 28, 2023↗ | Gregory Ginger | EVP, Human Resources | Sell | 2,681 | $300.00 | $804.3K | 0 |
| Apr 4, 2023↗ | Singhal Priya | Head of Development | Sell | 91 | $277.11 | $25.2K | 0 |
| Mar 31, 2023↗ | Murphy Nicole | Head of Pharm Ops and Tech | Sell | 116 | $278.03 | $32.3K | 0 |
| Mar 28, 2023↗ | Singhal Priya | Head of Development | Sell | 568 | $270.06 | $153.4K | 0 |
| Mar 2, 2023↗ | Singhal Priya | Head of Development | Sell | 687 | $268.75 | $184.6K | 0 |
| Feb 17, 2023↗ | ALEXANDER SUSAN H | EVP Chief Legal Off & Corp Sec | Sell | 929 | $278.38 | $258.6K | 0 |
| Feb 17, 2023↗ | Gregory Ginger | EVP, Human Resources | Sell | 867 | $278.38 | $241.4K | 0 |
| Feb 17, 2023↗ | Izzar Rachid | Head of Global Product Strat. | Sell | 371 | $278.38 | $103.3K | 0 |
| Feb 17, 2023↗ | Kramer Robin | Chief Accounting Officer | Sell | 238 | $278.38 | $66.3K | 0 |
| Feb 17, 2023↗ | MCDONNELL MICHAEL R | EVP, Chief Financial Officer | Sell | 1,310 | $278.38 | $364.7K | 0 |
| Feb 17, 2023↗ | Murphy Nicole | Head of Pharm Ops and Tech | Sell | 233 | $278.38 | $64.9K | 0 |
| Feb 17, 2023↗ | Singhal Priya | Head of Development | Sell | 151 | $278.38 | $42.0K | 0 |
| Feb 10, 2023↗ | ALEXANDER SUSAN H | EVP Chief Legal Off & Corp Sec | Sell | 4,202 | $286.30 | $1.20M | 0 |
| Feb 10, 2023↗ | Gregory Ginger | EVP, Human Resources | Sell | 3,306 | $286.30 | $946.5K | 0 |
| Feb 10, 2023↗ | Izzar Rachid | Head of Global Product Strat. | Sell | 1,324 | $286.30 | $379.1K | 0 |
| Feb 10, 2023↗ | Kramer Robin | Chief Accounting Officer | Sell | 590 | $286.30 | $168.9K | 0 |
| Feb 10, 2023↗ | MCDONNELL MICHAEL R | EVP, Chief Financial Officer | Sell | 1,105 | $286.30 | $316.4K | 0 |
| Feb 10, 2023↗ | Murphy Nicole | Head of Pharm Ops and Tech | Sell | 1,387 | $286.30 | $397.1K | 0 |
| Feb 10, 2023↗ | Singhal Priya | Head of Development | Sell | 372 | $286.30 | $106.5K | 0 |
| Dec 8, 2022↗ | Kramer Robin | Chief Accounting Officer | Sell | 156 | $289.10 | $45.1K | 0 |
| Dec 2, 2022↗ | Izzar Rachid | Head of Alzheimer's Disease | Sell | 759 | $298.90 | $226.9K | 0 |
| Dec 2, 2022↗ | Murphy Nicole | Head of Pharm Ops and Tech | Sell | 39 | $298.90 | $11.7K | 0 |
| Nov 14, 2022↗ | Gregory Ginger | EVP, Human Resources | Sell | 5,610 | $300.11 | $1.68M | 0 |
| Oct 27, 2022↗ | ALEXANDER SUSAN H | EVP Chief Legal Off & Corp Sec | Sell | 5,532 | $280.70 | $1.55M | 0 |
| Sep 1, 2022↗ | MCDONNELL MICHAEL R | EVP, Chief Financial Officer | Sell | 2,428 | $199.79 | $485.1K | 0 |
| Aug 1, 2022↗ | Murphy Nicole | Head of Pharm Ops and Tech | Sell | 319 | $209.26 | $66.8K | 0 |
| Jul 1, 2022↗ | Izzar Rachid | Head of Alzheimer's Disease | Sell | 148 | $210.63 | $31.2K | 0 |
| Jul 1, 2022↗ | Kramer Robin | Chief Accounting Officer | Sell | 74 | $210.63 | $15.6K | 0 |
| Apr 1, 2022↗ | Murphy Nicole | Head of Pharm Ops and Tech | Sell | 84 | $210.65 | $17.7K | 0 |
| Feb 18, 2022↗ | ALEXANDER SUSAN H | EVP Chief Legal Off & Corp Sec | Sell | 659 | $209.79 | $138.3K | 0 |
| Feb 18, 2022↗ | Gregory Ginger | EVP, Human Resources | Sell | 616 | $209.79 | $129.2K | 0 |
| Feb 18, 2022↗ | Guindo Chirfi | Head of Glob Prod Strat & Com | Sell | 879 | $209.79 | $184.4K | 0 |
| Feb 18, 2022↗ | Izzar Rachid | Head of Alzheimer's Disease | Sell | 175 | $209.79 | $36.7K | 0 |
| Feb 18, 2022↗ | Kramer Robin | Chief Accounting Officer | Sell | 117 | $209.79 | $24.5K | 0 |
| Feb 18, 2022↗ | MCDONNELL MICHAEL R | EVP, Chief Financial Officer | Sell | 977 | $209.79 | $205.0K | 0 |
| Feb 18, 2022↗ | Murphy Nicole | Head of Pharm Ops and Tech | Sell | 110 | $209.79 | $23.1K | 0 |
| Feb 18, 2022↗ | Vounatsos Michel | Chief Executive Officer | Sell | 2,746 | $209.79 | $576.1K | 0 |
| Feb 12, 2022↗ | ALEXANDER SUSAN H | EVP Chief Legal Off & Corp Sec | Sell | 2,056 | $214.59 | $441.2K | 0 |
| Feb 12, 2022↗ | Gregory Ginger | EVP, Human Resources | Sell | 1,252 | $214.59 | $268.7K | 0 |
| Feb 12, 2022↗ | Guindo Chirfi | Head of Glob Prod Strat & Com | Sell | 2,342 | $214.59 | $502.6K | 0 |
| Feb 12, 2022↗ | Izzar Rachid | Head of Alzheimer's Disease | Sell | 122 | $214.59 | $26.2K | 0 |
| Feb 12, 2022↗ | Kramer Robin | Chief Accounting Officer | Sell | 171 | $214.59 | $36.7K | 0 |
| Feb 12, 2022↗ | Murphy Nicole | Head of Pharm Ops and Tech | Sell | 92 | $214.59 | $19.7K | 0 |
| Feb 12, 2022↗ | Vounatsos Michel | Chief Executive Officer | Sell | 8,566 | $214.59 | $1.84M | 0 |
| Dec 3, 2021↗ | Kramer Robin | Chief Accounting Officer | Sell | 100 | $223.92 | $22.4K | 0 |
| Dec 2, 2021↗ | Izzar Rachid | Head of Alzheimer's Disease | Sell | 165 | $228.52 | $37.7K | 0 |
| Sep 1, 2021↗ | MCDONNELL MICHAEL R | EVP, Chief Financial Officer | Sell | 2,582 | $338.24 | $873.3K | 0 |
| Jul 1, 2021↗ | Kramer Robin | Chief Accounting Officer | Sell | 74 | $348.92 | $25.8K | 0 |
| Jun 7, 2021↗ | Guindo Chirfi | Head of Glob Prod Strat & Com | Sell | 3,087 | $440.00 | $1.36M | 0 |
| Jun 7, 2021↗ | Sandrock Alfred | Head of Research & Development | Sell | 7,672 | $440.00 | $3.38M | 0 |
| Jun 4, 2021↗ | Posner Brian S | Director | Sell | 360 | $274.17 | $98.7K | 0 |
BIIB Insiders
Similar Stocks to BIIB
LLY
Eli Lilly and Company
$984.11+0.70%
$921.90B
JNJ
Johnson & Johnson
$241.86-0.07%
$583.29B
ABBV
AbbVie Inc.
$220.81-2.02%
$398.49B
MRK
Merck & Co., Inc.
$115.92+0.00%
$286.57B
AMGN
Amgen Inc.
$366.74-0.29%
$198.26B
GILD
Gilead Sciences, Inc.
$144.25-0.66%
$180.27B
PFE
Pfizer Inc.
$26.62-0.89%
$152.73B
BMY
Bristol-Myers Squibb Company
$58.93-0.04%
$120.05B